Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Conventional lifestyle modification for type 2 diabetes involves 7% weight loss, avoidance of high-energy foods, and 150 min of weekly exercise (1). Although effective at preventing and treating diabetes, this approach is not appropriate for those who do not need or want to lose weight or who cannot maintain weight loss. An alternative may be to target postprandial glucose (PPG), the major contributor to HbA1c (2). The GEM (glycemic load, exercise, and monitoring blood glucose) lifestyle modification program focuses on diminishing PPG by selecting low–glycemic load foods to prevent PPG spikes, reducing PPG with postprandial exercise, and using systematic self-monitoring of blood glucose (SMBG). Systematic SMBG educates individuals about the impact of different foods and physical activities on PPG, activates them to take action when glucose is outside of desired limits, and motivates them to repeat choices that produce desired glucose levels. Therefore, GEM represents a paradigm shift from reducing insulin resistance through reducing fat to reducing …
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In a small single arm pilot study of 4 participants, Cox and colleagues used the Dexcom 4 Platinum™ in conjunction with their glycaemic excursion minimisation (GEM) protocol and showed an HbA1c reduction of 0.9%.”
Citations
Cites
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Monnier, L., Lapinski, H., & Colette, C. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.881 · Cited by 1,461 · cited 4×
“Mean HbA1c fell from 7.8 to 6.7%, which is a greater improvement than the reduction from 8.4 to 7.4% in the preliminary study.”
BackgroundInfluentialVigersky, R. A., Fonda, S. J., Chellappa, M., Walker, M. S., & Ehrhardt, N. M. (2012) · Diabetes Care · doi:10.2337/dc11-1438 · Cited by 301
Farmer, A. J., Perera, R., Ward, A., Heneghan, C., Oke, J., Barnett, A. H., Davidson, M. B., Guerci, B., Coates, V., Schwedes, U., et al. (2012) · BMJ · doi:10.1136/bmj.e486 · Cited by 156
Cox, D. J., Taylor, A. G., Singh, H., Moncrief, M., Diamond, A., Yancy, W. S., Hegde, S., & McCall, A. L. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2015.10.021 · Cited by 21
Self-citation
Cited by
Chatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
Ruedy, K. J., Parkin, C. G., Riddlesworth, T. D., & Graham, C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817704445 · Cited by 225
Rodríguez, J., Camiña, F., Devesa, J. B. O., Rodríguez‐Segade, S., & Rodríguez, Á. (2025) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2025-0011 · Cited by 186
Taylor, P. J., Thompson, C. H., & Brinkworth, G. D. (2018) · Journal of Diabetes Investigation · doi:10.1111/jdi.12807 · Cited by 105
Ehrhardt, N., & Al Zaghal, E. (2019) · Journal of Diabetes Science and Technology · doi:10.1177/1932296818790994 · Cited by 105
Zahedani, A. D., McLaughlin, T., Veluvali, A., Aghaeepour, N., Hosseinian, A., Agarwal, S., Ruan, J., Tripathi, S., Woodward, M., Hashemi, N., et al. (2023) · npj Digital Medicine · doi:10.1038/s41746-023-00956-y · Cited by 96
“Three studies have previously examined the use of CGM for lifestyle change T2D 29 – 31 Cox et al. 29 included only four patients and did not have a control group.”
Oser, T. K., Hall, T. L., Dickinson, L. M., Callen, E., Carroll, J. K., Nease, D. E., Michaels, L., & Oser, S. M. (2022) · The Annals of Family Medicine · doi:10.1370/afm.2876 · Cited by 72
Continuous Glucose Monitoring As a Behavior Modification Tool
Ehrhardt, N., & Al Zaghal, E. (2020) · Clinical Diabetes · doi:10.2337/cd19-0037 · Cited by 69
Dehghani Zahedani, A., Shariat Torbaghan, S., Rahili, S., Karlin, K., Scilley, D., Thakkar, R., Saberi, M., Hashemi, N., Perelman, D., Aghaeepour, N., et al. (2021) · Diabetes Therapy · doi:10.1007/s13300-021-01081-3 · Cited by 62
Oser, T. K., Litchman, M. L., Allen, N. A., Kwan, B. M., Fisher, L., Jortberg, B. T., Polonsky, W. H., & Oser, S. M. (2021) · Current Diabetes Reports · doi:10.1007/s11892-021-01408-1 · Cited by 43
Clark, T. L., Polonsky, W. H., & Soriano, E. C. (2024) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0612 · Cited by 40
Battelino, T., Lalic, N. M., Hussain, S., Ceriello, A., Majanović, S. K., Davies, S., Topsever, P., Heverly, J., Ulivi, F., Brady, K., et al. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112111 · Cited by 36
Tan, Y. Y., Suan, E., Koh, G. C. H., Suhairi, S. B., & Tyagi, S. (2024) · Archives of Public Health · doi:10.1186/s13690-024-01459-2 · Cited by 35
Samson, S. L., Vellanki, P., Blonde, L., Hirsch, I. B., Hoang, T. D., Isaacs, S. D., Izuora, K. E., Wang, C. C. L., Ooi, C. P., Padilla, B. I., et al. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.01.006 · Cited by 34
Aronson, R., Abitbol, A., Bajaj, H. S., Cheng, A. Y. Y., Christopoulos, S., Harris, S. B., Jain, A. B., & Goldenberg, R. M. (2025) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.70008 · Cited by 33
Rivera-Ávila, D. A., Esquivel-Lu, A. I., Salazar-Lozano, C. R., Jones, K., & Doubova, S. V. (2021) · BMC Endocrine Disorders · doi:10.1186/s12902-021-00742-5 · Cited by 32
Gal, R. L., Cohen, N. J., Kruger, D., Beck, R. W., Bergenstal, R. M., Calhoun, P., Cushman, T., Haban, A., Hood, K., Johnson, M. L., et al. (2020) · Journal of the Endocrine Society · doi:10.1210/jendso/bvaa076 · Cited by 32
Evolving Use of Continuous Glucose Monitoring Beyond Intensive Insulin Treatment
Wright, E. E., & Subramanian, S. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0191 · Cited by 20
Zhang, D., Huang, J., Zhang, Y. H., Wei, Z., Long, T., Guo, X., & Li, M. (2025) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2025.112907 · Cited by 17
Evaluation of Patient Willingness to Adopt Remote Digital Monitoring for Diabetes Management
Oikonomidi, T., Ravaud, P., Cosson, E., Montori, V. M., & Tran, V.-T. (2021) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.33115 · Cited by 15
Cox, D. J., Fang, K., McCall, A. L., Conaway, M. R., Banton, T. A., MONCRIEF, M. A., Diamond, A. M., & Taylor, A. G. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0554-6 · Cited by 14
Self-citationCox, D. J., Oser, T., Moncrief, M., Conaway, M., & McCall, A. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002403 · Cited by 11
Self-citationWhat Role Might There Be for Continuous Glucose Monitoring in the Assessment of Diabetes Risk?
Miller, E. M., Polonsky, W. H., & Miller, K. (2023) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2023.0136 · Cited by 9
Weiner, M., Cummins, J., Raji, A., Ofner, S., Iglay, K., Teal, E. Y., Li, X., Engel, S. S., Knapp, K., Rajpathak, S. N., et al. (2020) · Current Medical Research and Opinion · doi:10.1080/03007995.2020.1717451 · Cited by 8
Unnikrishnan, A., Saboo, B., Joshi, S., Kesavadev, J., Makkar, B. M., Agarwal, S., Aravind, S. R., Seshadri, K., Chawla, M. S., Deshpande, N., et al. (2019) · PubMed · Cited by 7
Continuous Glucose Monitoring: An Opportunity for Population-Based Diabetes Management
Skoufalos, A., Thomas, R., Patel, R. R., Mei, C., & Clarke, J. L. (2022) · Population Health Management · doi:10.1089/pop.2022.0196 · Cited by 5
Heitkemper, E., Wilcox, G. B., Zuniga, J. A., Kim, M. T., & Cuevas, H. E. (2023) · The Science of Diabetes Self-Management and Care · doi:10.1177/26350106231158828 · Cited by 4
Health-Care Disparities in the Use of Diabetes Technologies in the UK
Barnard-Kelly, K. D., & Parkin, C. G. (2022) · International Journal of Diabetes and Technology · doi:10.4103/ijdt.ijdt_1_23 · Cited by 3
Rodríguez, Á., Rodríguez, J., Camiña, F., Devesa, J. B. O., & Rodríguez‐Segade, S. (2025) · Advances in Laboratory Medicine / Avances en Medicina de Laboratorio · doi:10.1515/almed-2024-0125 · Cited by 2
Nsr-Allah, A. A.-E. M., Kamar, M., Sharawy, A., & Raafat, N. (2018) · The Egyptian Journal of Internal Medicine · doi:10.4103/ejim.ejim_26_18 · Cited by 2
Cowart, K., Olson, K. W., & Carris, N. W. (2025) · Expert Review of Medical Devices · doi:10.1080/17434440.2025.2463339 · Cited by 1
Jolley, D. R. (2020) · ScholarWorks (Walden University) · Cited by 1
Koceva, A., Janež, A., & Jensterle, M. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1892632
A folyamatos glükózmonitorozás jelentősége a korszerű diabetesgondozásban
Kocsis, G. (2022) · Lege Artis Medicinae · doi:10.33616/lam.32.016
Willingness to adopt digital behavior change interventions in people with chronic conditions
Oikonomidi, T. (2021) · theses.fr (ABES) · doi:10.70675/1c55ba23zaa2az4f6ez987fz81d53ee22274
Nakayama, H., Hashinaga, T., Yamada, K., Wada, N., Inada, C., Iwata, S., Tokubuchi, I., Yoshinobu, S., Tanaka, Y., Nagayama, A., et al. (2026) · Diabetology International · doi:10.1007/s13340-026-00897-3
Johnson, D. J., Buchanan, L., Saner, E. M., Calkins, M. W., & Kirk, J. K. (2026) · Healthcare · doi:10.3390/healthcare14040420
Impact of CGM on Lifestyle Modifications and Diabetes Self-Management Practices
Ghabban, S., Ghabban, A., AL-Yusuf, M., & Alqarni, M. (2026) · Journal of Healthcare Sciences · doi:10.52533/johs.2026.60914
Metadata
- Authors
- Cox, D. J., Taylor, A. G., Moncrief, M., Diamond, A., Yancy, W. S., Hegde, S., & McCall, A. L.
- Affiliations
- University of Virginia (US)
- Duke University (US)
- Corresponding author
- Cox, Daniel J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2016-03-17
- Volume
- 39
- Issue
- 5
- Pages
- e71-e73
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2304287915
- Cited by
- 36
- References
- 6
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 3 · 2023: 3 · 2022: 4 · 2021: 7 · 2020: 3 · 2019: 1 · 2018: 4 · 2017: 2
- FWCI
- 2.34
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes Care (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- continuous glucose monitoring, type 2 diabetes, self-management, glycemic load, postprandial blood glucose, HbA1c, self-monitoring of blood glucose, postprandial exercise, lifestyle modification, weight loss
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.